Logo image of ALBT

AVALON GLOBOCARE CORP (ALBT) Stock Fundamental Analysis

NASDAQ:ALBT - Nasdaq - US05344R3021 - Common Stock

3.73  +0.07 (+1.91%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to ALBT. ALBT was compared to 65 industry peers in the Real Estate Management & Development industry. ALBT may be in some trouble as it scores bad on both profitability and health. ALBT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALBT had negative earnings in the past year.
ALBT had a negative operating cash flow in the past year.
ALBT had negative earnings in each of the past 5 years.
In the past 5 years ALBT always reported negative operating cash flow.
ALBT Yearly Net Income VS EBIT VS OCF VS FCFALBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -75.36%, ALBT is not doing good in the industry: 95.08% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -272.78%, ALBT is doing worse than 85.25% of the companies in the same industry.
Industry RankSector Rank
ROA -75.36%
ROE -272.78%
ROIC N/A
ROA(3y)-76.78%
ROA(5y)-104.98%
ROE(3y)-209.58%
ROE(5y)-268.15%
ROIC(3y)N/A
ROIC(5y)N/A
ALBT Yearly ROA, ROE, ROICALBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500

1.3 Margins

The Gross Margin of ALBT (21.33%) is comparable to the rest of the industry.
ALBT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALBT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.44%
GM growth 5Y-5.37%
ALBT Yearly Profit, Operating, Gross MarginsALBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

More info and screens

1

2. Health

2.1 Basic Checks

ALBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALBT has less shares outstanding than it did 1 year ago.
ALBT has less shares outstanding than it did 5 years ago.
ALBT has a worse debt/assets ratio than last year.
ALBT Yearly Shares OutstandingALBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALBT Yearly Total Debt VS Total AssetsALBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -7.16, we must say that ALBT is in the distress zone and has some risk of bankruptcy.
ALBT has a Altman-Z score of -7.16. This is amonst the worse of the industry: ALBT underperforms 93.44% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that ALBT is somewhat dependend on debt financing.
ALBT has a Debt to Equity ratio (0.73) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z -7.16
ROIC/WACCN/A
WACC10.01%
ALBT Yearly LT Debt VS Equity VS FCFALBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

ALBT has a Current Ratio of 0.11. This is a bad value and indicates that ALBT is not financially healthy enough and could expect problems in meeting its short term obligations.
ALBT has a worse Current ratio (0.11) than 93.44% of its industry peers.
A Quick Ratio of 0.11 indicates that ALBT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.11, ALBT is doing worse than 93.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
ALBT Yearly Current Assets VS Current LiabilitesALBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

ALBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2025.81%.
ALBT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.56%.
The Revenue has been decreasing by -4.25% on average over the past years.
EPS 1Y (TTM)-2025.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1197.48%
Revenue 1Y (TTM)5.56%
Revenue growth 3Y-3.1%
Revenue growth 5Y-4.25%
Sales Q2Q%4.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBT Yearly Revenue VS EstimatesALBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
ALBT Yearly EPS VS EstimatesALBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBT Price Earnings VS Forward Price EarningsALBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALBT Per share dataALBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVALON GLOBOCARE CORP

NASDAQ:ALBT (1/21/2025, 8:00:00 PM)

3.73

+0.07 (+1.91%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-12 2024-08-12/amc
Earnings (Next)N/A N/A
Inst Owners1.59%
Inst Owner Change0%
Ins Owners35.31%
Ins Owner ChangeN/A
Market Cap4.07M
AnalystsN/A
Price TargetN/A
Short Float %3.3%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.11
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-19.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.3
FCFYN/A
OCF(TTM)-4.3
OCFYN/A
SpS1.2
BVpS4.96
TBVpS4.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.36%
ROE -272.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.33%
FCFM N/A
ROA(3y)-76.78%
ROA(5y)-104.98%
ROE(3y)-209.58%
ROE(5y)-268.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.44%
GM growth 5Y-5.37%
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.23%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -7.16
F-Score4
WACC10.01%
ROIC/WACCN/A
Cap/Depr(3y)6.71%
Cap/Depr(5y)26.42%
Cap/Sales(3y)1.31%
Cap/Sales(5y)7.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2025.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1197.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.56%
Revenue growth 3Y-3.1%
Revenue growth 5Y-4.25%
Sales Q2Q%4.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.89%
OCF growth 3YN/A
OCF growth 5YN/A